Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance - 'Ichnos Glenmark Innovation'

Jan 31, 2024

Mumbai (Maharashtra) [India], January 31: Glenmark Pharmaceuticals Ltd. (Glenmark), a leading, research-driven, global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), its global fully integrated,...

Glenmark Pharma reports revenue growth of 13.9% and EBITDA growth of 30.8% YoY for Q3 FY 2021-22

Feb 12, 2022

Mumbai (Maharashtra) [India], February 12 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a global innovation-driven pharmaceutical company, today announced its financial results for the third quarter...

Glenmark Pharma reports revenue of Rs 27,773 Mn and PAT of Rs 2,111 Mn for Q1 FY 2022-23

Aug 11, 2022

Mumbai (Maharashtra) [India], August 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the first quarter...

Glenmark Pharma reports revenue growth of 5.6 per cent YoY Q4; 12.4 per cent for the full year FY 2021-22

May 30, 2022

Mumbai (Maharashtra) [India], May 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter...

Glenmark receives the 'India Pharma Innovation of the Year' Award from the Government of India

Apr 27, 2022

Mumbai (Maharashtra) [India], April 27 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company, today received the 'India Pharma Innovation of the Year'...

Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the US

Aug 31, 2022

London [UK]/ Mahwah (New Jersey) [US], Mumbai (Maharashtra) [India], August 31 (ANI/PRNewswire): Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty...